![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-e60744930b7a757f7da18c7ae7c790bd3bdc57d2896c509cf6dbb30763b9aa83.jpg)
Stereotactic Ablative Radiotherapy for the Treatment of Oligometastatic Cancer
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.